insights_auto
Nega 543904 tushdi 3,39%?
Batafsil oʻrganishchevron_right
543904:BOM
Mankind Pharma Ltd
2 275,00 ₹
arrow_downward
-3,39%(-79,80) 1K
16-okt, 15:50:40 (GMT+5:30) · INR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto543904 tikeri uchun statistika yaratilmoqda...
Ochish
2 354,60 ₹
Yuqori
2 355,00 ₹
Past
2 269,00 ₹
Bozor kapitali
937,40 mlrd
Oʻrtacha hajm
40,89 ming
Hajmi
32,86 ming
P/E koeffitsiyenti
46,03
52 haftalik eng yuqori
2 640,30 ₹
52 haftalik eng past
1 909,90 ₹
Aksiya boʻyicha daromad
49,42 ₹
Xodimlar soni
20 ming
Ochish
2 354,60 ₹
Yuqori
2 355,00 ₹
Past
2 269,00 ₹
Bozor kapitali
937,40 mlrd
Oʻrtacha hajm
40,89 ming
Hajmi
32,86 ming
P/E koeffitsiyenti
46,03
52 haftalik eng yuqori
2 640,30 ₹
52 haftalik eng past
1 909,90 ₹
Aksiya boʻyicha daromad
49,42 ₹
Xodimlar soni
20 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Pharma Letter
·
22 soat oldin
Lakefront sells CAR-T programs as Mankind agrees Armed Cell investment
Business Standard
·
1 kun oldin
Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million
Profil
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Mankind Pharma Ltd haqida
CEORajeev Juneja | Sheetal Arora
Xodimlar soni20,5 ming
Asos solingan1991
Bosh ofislar-
Sektor-
Veb-saytmankindpharma.com